Datapunk Opus23 | Bifidobacterium adolescentis

Bifidobacterium adolescentis

RANK: Species

TAXONOMY: Terrabacteria group -> Actinobacteria -> Actinobacteria -> Bifidobacteriales -> Bifidobacteriaceae -> Bifidobacterium -> Bifidobacterium adolescentis

OVERVIEW:

Bifidobacterium adolescentis are normal inhabitants of healthy human and animal intestinal tracts. Colonization of B. adolescentis in the gut occurs immediately after birth. Their population in the gut tends to maintain relative stability until late adulthood, where factors such as diet, stress, and antibiotics causes it to decline . This species was first isolated by Tissier in 1899 in the feces of breast-fed newborns. Tissier was the first to promote the therapeutic use of bifidobacteria for treating infant diarrhea by giving them large doses of bifidobacteria orally. Since then, their presence in the gut has been associated with a healthy microbiota. The correlation between the presence of bifidobacteria and gastrointestinal health has produced numerous studies focusing on gastrointestinal ecology and the health-promoting aspects that bifidobacteria are involved in. Obtaining more information about specific strains of bifidobacteria and their roles in the gastrointestinal tract have been on the rise as these probiotic organisms are being used as food additives, such as dairy products. Their name is derived from the observation that these bacteria often exist in a Y-shaped, or bifid form Direct sub-taxa of Bifidobacterium adolescentis: Bifidobacterium adolescentis ATCC 15703, Bifidobacterium adolescentis DSM 20087, Bifidobacterium adolescentis L2-32, Bifidobacterium adolescentis XVI-120, Bifidobacterium adolescentis XVI122 Identified as constituent of vaginal microbiome. [PMID:23282177] Eubacterium rectale and Bacteroides thetaiotaomicron showed limited ability to utilize RS2- and RS3-resistant starches by comparison with Bifidobacterium adolescentis and Ruminococcus bromii. [PMID: 22343308]

This species has been identified as a resident in the human gastrointestinal tract based on the phylogenetic framework of its small subunit ribosomal RNA gene sequences.[PMC 4262072]

COGEM

COGEM released a comprehensive database of pathogenicity assessment of around 2575 bacterial species in 2011. The database ranks the pathogenicity of species on a scale of 1 to 4. Bifidobacterium adolescentis ranks on this scale:

Identified as a 'core species' of the human gut microbiome. [PMID: 23222524]

TAGS

Keystone	Core species	Type species	Pathogen	Dysbiosis associated	Flora/ commensal	Gut associated	Probiotic
Leanness	Obesity	Skin microbiome	Fecal distribution	Oral microbiome	Vaginal microbiome	Butyrate producer	Catalase producer
Histamine producer	Food fermenter	Amylolytic	Propionate producer	Nitrifying	Biofilm producer

INTERACTIONS ENHANCES Bacteroidales Bacteroides Odoribacter Roseburia Peptococcaceae INHIBITS Bifidobacterium Coriobacteriales Adlercreutzia Collinsella Porphyromonas Prevotella Clostridium Clostridiales incertae sedis Clostridiales Family XIII. Incertae Sedis Blautia Coprococcus Dorea Lachnospiraceae Ruminococcaceae Ruminococcus Dialister Campylobacteraceae Erysipelotrichaceae INHIBITED BY Bifidobacterium Coriobacteriales Adlercreutzia Collinsella Bacteroidales Bacteroides Porphyromonadaceae Odoribacter Parabacteroides Porphyromonas Prevotella Rikenellaceae Alistipes Turicibacter Streptococcus Clostridiales Catabacteriaceae Clostridium Clostridiales incertae sedis Peptoniphilus Clostridiales Family XIII. Incertae Sedis Lachnospiraceae Blautia Lachnospiraceae Coprococcus Dorea Eubacterium Lachnobacterium Lachnospira Roseburia Lachnospiraceae Peptococcaceae Ruminococcaceae Ruminiclostridium Acetivibrio Eubacterium Faecalibacterium Oscillospira Ruminococcus Acidaminococcus Dialister Phascolarctobacterium Veillonella Rubrivivax Alcaligenaceae Oxalobacter Bilophila Desulfovibrio Campylobacteraceae Enterobacteriaceae Escherichia Erysipelotrichaceae Erysipelotrichaceae Holdemania Akkermansia	KEGG PATHWAYS CLUSTERS WITH Group 92 Bifidobacterium adolescentis Fusobacterium nucleatum Bacteroides thetaiotaomicron Group 33 Peptoclostridium difficile Bifidobacterium adolescentis Clostridium tetani Clostridium botulinum Clostridium perfringens Clostridium beijerinckii Clostridium novyi Group 4 Streptococcus mutans Leuconostoc mesenteroides Lactobacillus salivarius Lactobacillus acidophilus Bifidobacterium adolescentis Streptococcus thermophilus Lactobacillus gasseri Pediococcus pentosaceus Clostridium perfringens Listeria innocua Lactobacillus sakei Bifidobacterium longum Lactobacillus johnsonii Streptococcus sanguinis Lactobacillus casei Lactobacillus brevis Streptococcus gordonii Lactobacillus delbrueckii Group 56 Bifidobacterium adolescentis Lactobacillus johnsonii Bifidobacterium longum Clostridium beijerinckii Streptococcus thermophilus Lactobacillus gasseri Leifsonia xyli Group 2 Leuconostoc mesenteroides Lactobacillus salivarius Lactobacillus acidophilus Bifidobacterium adolescentis Lactobacillus plantarum Streptococcus thermophilus Oenococcus oeni Listeria monocytogenes Lactobacillus gasseri Chloroflexus aurantiacus Bacillus pumilus Pediococcus pentosaceus Bacillus licheniformis Listeria innocua Lactobacillus sakei Clostridium acetobutylicum Bifidobacterium longum Lactobacillus johnsonii Lactobacillus brevis Lactococcus lactis Streptococcus gordonii Lactobacillus delbrueckii Group 5 Staphylococcus epidermidis Lactobacillus acidophilus Bifidobacterium adolescentis Chloroflexus aurantiacus Neisseria gonorrhoeae Saccharophagus degradans Cytophaga hutchinsonii Bacteroides fragilis Clostridium perfringens Enterobacter Propionibacterium acnes Gramella forsetii Clostridium acetobutylicum Staphylococcus aureus Porphyromonas gingivalis Bifidobacterium longum Colwellia psychrerythraea Pseudomonas aeruginosa Bacteroides thetaiotaomicron Haemophilus influenzae Peptoclostridium difficile Fusobacterium nucleatum	METABOLOMICS NUTRIENTS/ SUBSTRATES Ellagic acid [parent] D-Glucose [parent] Raffinose [parent] Stachyose (soy oligosaccharide) [parent] Resistant starch (type II) Taraxacum officinale (dandelion root) [parent] ENDPRODUCTS Urolithins [parent] Propionate γ-Amino butyric acid (GABA) [parent] Folate [parent] Biotin [parent] Lactic acid [parent] INHIBITED BY Laminaria hyperborea (curvie) [parent] Chemotherapy [parent] Magnesium-deficient diet [parent] Low carbohydrate diet [parent] Glyphosphate [parent] High fat diet [parent] Ascophyllum nodosum (rockweed) [parent] Berberine [parent] Sucralose (Splenda) [parent] Low FODMAP diet [parent] ENHANCED BY Resistant starch (type III) Red wine [parent] Navy bean (Cooked) [parent] Resistant starch (type II) Resistant starch (type III) [parent] Ketogenic diet [parent] Inulin [parent] Chondrus crispus (red seaweed) [parent] Resveratrol [parent] Resistant starch (type I) Sesame cake/meal [parent] Almonds/ almond skins [parent] Green tea [parent] Jerusalem artichoke [parent] Fructo-oligosaccharides [parent] Chicory [parent] Magnesium [parent] Arabinoxylans [parent] Daesiho-tang (DSHT) [parent] BIOTRANSFORMS Daidzein [parent] Linoleic acid (LA) [parent] Linolenic acid (CLnA) [parent] Ginsenoside Rb1 [parent] Bile acids BIOTRANFORM Trans-11 conjugate linoleic acid (CLA) [parent] Cis-9 conjugate linoleic acid (CLA) [parent] Equol sulphate [parent] Cis-15 conjugate linolenic acids (CLnA) [parent] Cis-9 conjugate linolenic acids (CLnA) [parent] Trans-11 conjugate linolenic acids (CLnA) [parent]
ANTIBIOTIC RESISTANCE See Parent Genus (Bifidobacterium)	BIOFILM FORMERS See Parent Genus (Bifidobacterium)	COGEM PATHOGENICITY See Parent Genus (Bifidobacterium)

OPUS 23™ IS A REGISTERED TRADEMARK ® OF DATAPUNK BIOINFORMATICS, LLC. COPYRIGHT © 2015-2023. ALL RIGHTS RESERVED. |